Article info

Download PDFPDF

Severe early hepatitis B reactivation in a patient receiving anti-CD19 and anti-CD22 CAR T cells for the treatment of diffuse large B-cell lymphoma

Authors

  1. e 86-27-83665506 doctormeng{at}163.com
View Full Text

Citation

Wei J, Zhu X, Mao X, et al
Severe early hepatitis B reactivation in a patient receiving anti-CD19 and anti-CD22 CAR T cells for the treatment of diffuse large B-cell lymphoma

Publication history

  • Received July 31, 2019
  • Accepted October 25, 2019
  • First published November 21, 2019.
Online issue publication 
November 21, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.